AV7909
AV7909 [anthrax vaccine adsorbed (AVA), adjuvant] is being studied for use as a third generation anthrax vaccine. This candidate consists of BioThrax® (Anthrax Vaccine Adsorbed) in combination with a novel immunostimulatory compound, CPG 7909.
Availability: In Development
| Manufacturer |
| Emergent BioSolutions, Inc. |
| Product Name |
| AV7909 |
| Detection Category |
| Biological |
| Detection Method |
| Medical Countermeasure |
| Application |
| Personal Protective Equipment; |
| Equipment Type |
| PPE |
| Product Synopsis |
| AV7909 [anthrax vaccine adsorbed (AVA), adjuvant] is being studied for use as a third generation anthrax vaccine. This candidate consists of BioThrax® (Anthrax Vaccine Adsorbed) in combination with a novel immunostimulatory compound, CPG 7909. |
| Availability |
| In Development |
| Technology Readiness Level (TRL) |
| 7 |
| User Feedback Sources |
| Indifferent/No user feedback |
| Weight |
| <1 lb. |
| Power Requirements |
| None |
| Transportability |
| Pocket Size |
| Live Agent Tested |
| Yes; B. anthracis (anthrax) |
| Material |
| BioThrax® (Anthrax Vaccine Adsorbed) in combination with a immunostimulatory compound, CPG 7909. |
| Operating Time |
| Preventative administration prior to exposure |
| Training Required |
| <1 hour training |
| Manuals Available |
| Yes |
